Current Research Studies

A Phase II Prospective Study Evaluating Selective Depletion of CD45RA+ T Cells Naïve T Cells (TND) from Peripheral Blood Stem Cell (PBSC) Grafts for Prevention of Graft versus Host Disease (GVHD) in Non-Malignant Diseases (NMDs)

TND HCT for GVHD prevention in NMD

  • Condition(s): Other
  • Phase: II
  • Clinicaltrials.gov ID: NCT07660783

What is the goal of the study?

Phase II Study of TND from PBSC grafts for prevention of GVHD in patients age 6 mo to 50 years with Non-Malignant Diseases

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: